Singh Nina, Husain Shahid, de Vera Michael, Gayowski Timothy, Cacciarelli Thomas V
From Veterans Affairs Medical Center and University of Pittsburgh Medical Center, Thomas E. Starzl Transplantation Institute, Pittsburgh, Pennsylvania.
Medicine (Baltimore). 2004 May;83(3):188-192. doi: 10.1097/01.md.0000126760.45299.69.
We reviewed the cases of patients with cirrhosis, including liver transplant candidates, at our institution in the last 3 years (n = 5) and those individually described in the literature (n = 28), to assess unique characteristics and outcome of cryptococcosis in these patients. Sixty-four percent (21/33) of the patients had no other recognized immunosuppression. Peritonitis (in 45%, 15/33 of the patients) with modest pleocytosis in the ascitic fluid, was the most common presenting feature. Median time to detection of Cryptococcus in the ascitic fluid cultures was 6 days. Overall mortality rate was 81% (26/32); death was deemed attributable to cryptococcosis in 24/26 patients who died. Evaluation of culture-negative neutrocytic ascites in febrile cirrhotic patients warrants consideration of cryptococcal peritonitis.
我们回顾了过去3年在我们机构的肝硬化患者病例,包括肝移植候选者(n = 5)以及文献中单独描述的病例(n = 28),以评估这些患者隐球菌病的独特特征和结局。64%(21/33)的患者没有其他公认的免疫抑制情况。腹膜炎(45%,15/33的患者)伴腹水轻度淋巴细胞增多是最常见的表现特征。腹水培养中检测到隐球菌的中位时间为6天。总体死亡率为81%(26/32);在26例死亡患者中,24例被认为死于隐球菌病。对于发热性肝硬化患者中培养阴性的中性粒细胞性腹水进行评估时,应考虑隐球菌性腹膜炎。